Literature DB >> 32279101

Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.

Shuai Ren1,2,3, Rui Zhao1, Jingjing Zhang1, Kai Guo1, Xiaoyu Gu1, Shaofeng Duan4, Zhongqiu Wang5, Rong Chen3.   

Abstract

PURPOSE: To investigate the value of texture analysis on unenhanced computed tomography (CT) to potentially differentiate mass-forming pancreatitis (MFP) from pancreatic ductal adenocarcinoma (PDAC).
METHODS: A retrospective study consisting of 109 patients (30 MFP patients vs 79 PDAC patients) who underwent preoperative unenhanced CT between January 2012 and December 2017 was performed. Synthetic minority oversampling technique (SMOTE) algorithm was adopted to reconstruct and balance MFP and PDAC samples. A total of 396 radiomic features were extracted from unenhanced CT images. Mann-Whitney U test and minimum redundancy maximum relevance (MRMR) methods were used for the purpose of dimension reduction. Predictive models were constructed using random forest (RF) method, and were validated using leave group out cross-validation (LGOCV) method. Diagnostic performance of the predictive model, including sensitivity, specificity, accuracy, positive predicting value (PPV), and negative predicting value (NPV), was recorded.
RESULTS: We applied 200% of SMOTE to MFP and PDAC patients, resulting in 90 MFP patients compared with 120 PDAC patients. Dimension reduction steps yielded 30 radiomic features using Mann-Whitney U test and MRMR methods. Ten radiomic features were retained using RF method. Four most predictive parameters, including GreyLevelNonuniformity_angle90_offset1, VoxelValueSum, HaraVariance, and ClusterProminence_AllDirection_offset1_SD, were used to generate the predictive model with preferable 92.2% sensitivity, 94.2% specificity, 93.3% accuracy, 92.2% PPV, and 94.2% NPV. Finally, in LGOCV analysis, a high pooled mean sensitivity, specificity, and accuracy (82.6%, 80.8%, and 82.1%, respectively) indicate a relatively reliable and stable predictive model.
CONCLUSIONS: Unenhanced CT texture analysis can be a promising noninvasive method in discriminating MFP from PDAC.

Entities:  

Keywords:  Adenocarcinoma; CT; Diagnosis; Pancreas; Pancreatitis; Radiomics

Mesh:

Substances:

Year:  2020        PMID: 32279101     DOI: 10.1007/s00261-020-02506-6

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  9 in total

1.  Retrospective Analysis of the Value of Enhanced CT Radiomics Analysis in the Differential Diagnosis Between Pancreatic Cancer and Chronic Pancreatitis.

Authors:  Xi Ma; Yu-Rui Wang; Li-Yong Zhuo; Xiao-Ping Yin; Jia-Liang Ren; Cai-Ying Li; Li-Hong Xing; Tong-Tong Zheng
Journal:  Int J Gen Med       Date:  2022-01-06

Review 2.  Radiomics and Its Applications and Progress in Pancreatitis: A Current State of the Art Review.

Authors:  Gaowu Yan; Gaowen Yan; Hongwei Li; Hongwei Liang; Chen Peng; Anup Bhetuwal; Morgan A McClure; Yongmei Li; Guoqing Yang; Yong Li; Linwei Zhao; Xiaoping Fan
Journal:  Front Med (Lausanne)       Date:  2022-06-23

3.  Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma.

Authors:  Shuai Ren; Rui Zhao; Wenjing Cui; Wenli Qiu; Kai Guo; Yingying Cao; Shaofeng Duan; Zhongqiu Wang; Rong Chen
Journal:  Front Oncol       Date:  2020-08-25       Impact factor: 6.244

4.  Deep learning radiomics based on contrast-enhanced ultrasound images for assisted diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis.

Authors:  Tong Tong; Jionghui Gu; Dong Xu; Ling Song; Qiyu Zhao; Fang Cheng; Zhiqiang Yuan; Shuyuan Tian; Xin Yang; Jie Tian; Kun Wang; Tian'an Jiang
Journal:  BMC Med       Date:  2022-03-02       Impact factor: 8.775

5.  Multi-Phase CT-Based Radiomics Nomogram for Discrimination Between Pancreatic Serous Cystic Neoplasm From Mucinous Cystic Neoplasm.

Authors:  Jiahao Gao; Fang Han; Xiaoshuang Wang; Shaofeng Duan; Jiawen Zhang
Journal:  Front Oncol       Date:  2021-12-01       Impact factor: 6.244

Review 6.  The impact of radiomics in diagnosis and staging of pancreatic cancer.

Authors:  Calogero Casà; Antonio Piras; Andrea D'Aviero; Francesco Preziosi; Silvia Mariani; Davide Cusumano; Angela Romano; Ivo Boskoski; Jacopo Lenkowicz; Nicola Dinapoli; Francesco Cellini; Maria Antonietta Gambacorta; Vincenzo Valentini; Gian Carlo Mattiucci; Luca Boldrini
Journal:  Ther Adv Gastrointest Endosc       Date:  2022-03-16

Review 7.  Setting the Research Agenda for Clinical Artificial Intelligence in Pancreatic Adenocarcinoma Imaging.

Authors:  Megan Schuurmans; Natália Alves; Pierpaolo Vendittelli; Henkjan Huisman; John Hermans
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

8.  A systematic review of radiomics in pancreatitis: applying the evidence level rating tool for promoting clinical transferability.

Authors:  Jingyu Zhong; Yangfan Hu; Yue Xing; Xiang Ge; Defang Ding; Huan Zhang; Weiwu Yao
Journal:  Insights Imaging       Date:  2022-08-20

9.  Development of CT-Based Imaging Signature for Preoperative Prediction of Invasive Behavior in Pancreatic Solid Pseudopapillary Neoplasm.

Authors:  Wen-Peng Huang; Si-Yun Liu; Yi-Jing Han; Li-Ming Li; Pan Liang; Jian-Bo Gao
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.